BTG (LSE: BTG) has expanded its pulmonary embolism (PE) business by acquiring Novate Medical Ltd., a startup focused on the prevention of PE in patients at high risk of venous thromboembolic events. Founded in 2006, Novate (Galway, Ireland) develops inferior vena cava (IVC) filters to reduce the likelihood of pulmonary embolism in high-risk clinical situations. Its […]